je.st
news
Wockhardt receives coveted QIDP status from FDA for WCK 771 and WCK 2349 drugs
2014-09-01 09:56:36| Biotech - Topix.net
Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349, received the coveted Qualified Infectious Disease Product status from U.S. Food & Drug Administration .
Tags: status
drugs
receives
fda
Category:Biotechnology and Pharmaceuticals